Last reviewed · How we verify
CLS12311 high
At a glance
| Generic name | CLS12311 high |
|---|---|
| Sponsor | Cellerys AG |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CLS12311 high CI brief — competitive landscape report
- CLS12311 high updates RSS · CI watch RSS
- Cellerys AG portfolio CI